Back to Search Start Over

A clinical approach to an unidentified aerosolized bioterrorism agent: a narrative review for emergency providers.

Authors :
Alremeithi R
Sullivan N
Checkeye H
Mazer-Amirshahi M
Pourmand A
Source :
Clinical and experimental emergency medicine [Clin Exp Emerg Med] 2023 Jun; Vol. 10 (2), pp. 147-156. Date of Electronic Publication: 2023 Feb 16.
Publication Year :
2023

Abstract

The current heightened international political climate is accompanied by increased risk of chemical or biological agent weaponization. Historical accounts of biochemical warfare are extensive, and considering the recent use of such agents for targeted attacks, clinicians need to recognize and manage these cases. However, agent properties such as the color, odor, ability to be aerosolized, and long incubation period can introduce difficulties in the diagnostic and management approach. We searched PubMed and Scopus for a colorless, odorless, aerosolized substance with an incubation period of at least 4 hours. Data from articles were summarized and reported by agent. Based on data from the available literature, we included agents such as nerve agents, ricin, botulinum toxin, anthrax, tularemia, and psittacosis in this review. We also highlighted potential chemical and biological agents that could be weaponized and the optimal strategies for the diagnosis and treatment of patients exposed to an unknown aerosolized biological or chemical bioterrorism agent.

Details

Language :
English
ISSN :
2383-4625
Volume :
10
Issue :
2
Database :
MEDLINE
Journal :
Clinical and experimental emergency medicine
Publication Type :
Academic Journal
Accession number :
36796783
Full Text :
https://doi.org/10.15441/ceem.22.412